AstraZeneca’s Evinova Revolutionizes Clinical Trials with AI-Powered Drug Development

AstraZeneca, a pharmaceutical juggernaut, has unveiled Evinova, a digital health company dedicated to AI-Powered Drug Development, set to operate independently within the AstraZeneca ecosystem. The key to this development lies in the amalgamation of scientific expertise and AI-enabled digital technologies at scale, as AstraZeneca endeavors to reshape the landscape of clinical trials and drug development. ... Read more